Anavex Life Sciences Corp (AVXL)

[F1ash]

So, if they reveal PK/PD data and full bottom line results to investors, then they would for some reason no longer be able to let Ariana do its analysis as well?

Have you at least considered the possibility that they are reluctant to reveal the data for fear that the same thing will happen to them that happened to Neurotrope?

Investors realized that a lower dose did better than a higher dose and gutted the share price based on mainly that fact alone, imho. If that's the case, it's wise to keep that information out of investors hands for as long as possible.

If the dose response curve looks beautiful, then it's a boneheaded move to be tapping LPC for over 6 million shares without showing investors that reassuring data. Wouldn't you agree?